Enochian BioSciences Announces Its Successful Completion of FDA INTERACT Meeting for a Potential Cure for HIV

NEXT STORY
NGM Bio Expands Board of Directors with Appointment of Carole Ho, M.D.
PREV STORY
Influenza Vaccines Market to Rise at 7.7% CAGR till 2026; Increasing Demand for Effective Flu Vaccines to Aid Market Expansion: Fortune Business Insights™
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Invuity Announces 2016 Third Quarter, Nine-Month Results Release and Conference Call Date

SAN FRANCISCO, Oct. 25, 2016 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading surgical ...

author_avatar
NASDAQ Market News

Oncology Venture A/S publicerar halvårsrapport för perioden januari – juni 2018

Oncology Venture A/S ("Oncology Venture", tidigare Medical Prognosis Institute A/S) publicerar härmed halvårsrapport avseende ...

author_avatar
NASDAQ Market News

RedHill Biopharma Receives Allowance for New U.S. Patent Covering RHB-106, an Encapsulated Bowel Preparation

Once granted, the new formulation patent is expected to be valid until at least ...

author_avatar
NASDAQ Market News